Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

Shanna L BurkeJanice O'DriscollAmary AlcideTan Li

Published in: International journal of geriatric psychiatry (2016)

The results of this study suggest that anxiolytics may moderate the effect of anxiety on MCI and AD development, specifically indicating a neutralized hazard for those with ɛ4 carriers with anxiety. Copyright © 2016 John Wiley & Sons, Ltd.

Keyphrases

sleep quality
mild cognitive impairment
cognitive decline
high intensity
social support
depressive symptoms